• Profile
Close

Diagnostic accuracy of whole-body MRI vs standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: The prospective Streamline C trial

The Lancet: Gastroenterology & Hepatology Jun 09, 2019

Taylor SA, et al. - In the prospective Streamline C trial with 1020 subjects, investigators prospectively compared the diagnostic accuracy and effectiveness of whole-body MRI (WB-MRI)-based staging pathways with standard pathways in colorectal cancer. Patients eligible with newly diagnosed colorectal cancer were 18 years of age or older. Pathway sensitivity was 67% for WB-MRI and 63% for standard pathways and agreement with the multidisciplinary team's final treatment decision was 96% for WB-MRI and 95% for the standard pathway. Findings indicated that WB-MRI staging pathways have similar accuracy to standard pathways and decrease the number of tests, staging time and cost required. Data reported that the mean staging costs per-patient were £216 for WB-MRI and £285 for standard pathways. No adverse image-related events have been reported.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay